Counterfeit malaria and tuberculosis medicines have killed more than 700,000 people worldwide. The counterfeit drug epidemic costs pharmaceutical companies over $200 Billion dollars each year. Securing Industry interviewed Ara Ohanian to learn how Systech’s latest technology provides the first true end-to-end supply chain visibility available in the market.

“Systech360 takes 30 years of Systech’s experience in serialization, track-and-trace, and authentication and put them under one umbrella , so users can see exactly where the vulnerabilities in their distribution channels are,” said Ohanian.

“Even large, sophisticated pharma companies are fighting tomorrow’s threat with yesterday’s weaponry” and are also “partially blind…because they don’t have visibility in their supply chains,” he added.

Read the full interview here.

 

WEBINAR | June 6th at 10am EST/4pm CET
IDC-logo

Pharma supply chain insights to action

with IDC Analysts

Exclusive data-driven session on “Solving the Critical Pharmaceutical Supply Chain Challenges” with the latest research findings on industry trends and innovative technologies to address market needs.